Congress Weighs Repeal of Tax Credit for Rare Disease Drugs Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul. Share: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook Related Posts:Rumbling MAGMA in SUPER volcano could hold KEY to SAVING millions of lives, study revealsQ&A: The Ocean Breathes So We Can, TooPatients Eagerly Awaited a Generic Drug. Then They Saw the Price.Geothermal Energy Grows in KenyaIn Australia, Custom-Made Milk Formulas Aid Exotic Mammals Like MarsupialsAfter Years of Fighting, Idaho Retains Climate Change in Its Education Guidelines
